WaveDancer Enters into Merger Agreement with Firefly Neuroscience

WaveDancer announced that it has entered into a definitive merger agreement with privately held, commercial-stage, medical technology company, Firefly Neuroscience, Inc., to combine the companies in an all-stock transaction. The combined company will focus on continuing to develop and commercialize Firefly’s Artificial Intelligence driven Brain Network Analytics (BNA™) platform, which was previously cleared by the U.S. Food and Drug Administration. Upon closing, which is currently expected in Q1-2024, the combined company is expected to operate under the name Firefly Neuroscience, Inc., and trade on the Nasdaq Global Market.

Read the full press release here.

Learn how Tellenger solves government and commercial business problems through IT development, modernization efforts, and cybersecurity programs. Learn more. 

Firefly Neuroscience
Firefly Neuroscience brings objective measurements of brain activity to the mental health and neurological disorder space… because you can’t manage what you can’t measure. Learn more.
© 2023 WaveDancer. All rights reserved.